ArticleHemaSphere2024

First-line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age-matched general population: A pooled post hoc analysis.

Paolo Ghia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.